Harvard Clinical Endocrinology 2025

Overview

Harvard Clinical Endocrinology 2025 is a comprehensive on-demand digital course providing the latest updates and clinical strategies for endocrine care. Delivered by faculty from Harvard Medical School and Massachusetts General Hospital, this program offers evidence-based guidance on the diagnosis and management of a wide range of endocrine disorders.

On-demand Endocrinology & Metabolism education — accessible anytime, anywhere.

Content

This course delivers practical, state-of-the-art updates for clinicians managing endocrine conditions. Topics include improved screening, new clinical guidelines, advanced diagnostic techniques, treatment options, and management of challenging cases.

• Improved screening for common endocrine conditions
• New clinical guidelines, including primary hyperparathyroidism and hypoparathyroidism
• Expanded diagnostic options and state-of-the-art treatment strategies
• Management updates for common and rare endocrine disorders
• New concepts in endocrinology and diabetes care
• Pediatric endocrinology updates
• Skill workshops on thyroid ultrasound, insulin pump management, and continuous glucose monitoring (CGM)
• Dedicated expert Q&A sessions

The course covers a broad spectrum of endocrine topics, including:

• Pituitary lesions and disorders (pituitary hormone excess, hypopituitarism)
• Adrenal conditions and incidentalomas
• Reproductive endocrine disorders in both sexes
• Calcium and bone metabolism disorders, including osteoporosis
• Thyroid diseases, including nodules and dysfunction
• Diabetes management for type 1, type 2, and pregnancy-related diabetes
• Obesity and lipid disorders

Additional detailed subjects include:

• Acromegaly
• Adult growth hormone deficiency
• Cushing’s disease
• Erectile dysfunction
• Gestational diabetes
• Glucocorticoid-induced osteoporosis
• Graves’ eye disease
• Hyper- and hypoparathyroidism
• Hyperprolactinemia
• Hypo- and hypercalcemia
• Hypoglycemia
• Insulin pumps, CGM, and technological advances in type 1 diabetes management
• Male and female hypogonadism
• Menopause
• Obesity and weight management
• Osteoporosis
• Pheochromocytoma
• Pituitary surgery and radiation
• Polycystic ovarian syndrome and hyperandrogenism
• Primary aldosteronism
• Sellar region abnormalities
• Thyroid cancer
• Thyroid disease during pregnancy
• Thyroid ultrasound techniques
• Transgender care

Speakers

This course features faculty from Harvard Medical School and Massachusetts General Hospital, recognized for their expertise in clinical endocrinology, research, and medical education. Their instruction provides authoritative updates and practical strategies relevant to endocrine practice.

Target Audience

This program is designed for endocrinologists, internists, pediatricians, obstetricians, gynecologists, and other healthcare professionals involved in the diagnosis and management of endocrine disorders. It is appropriate for clinicians seeking to reinforce their endocrine knowledge and clinical decision-making.

Why This Topic Matters

Harvard Clinical Endocrinology 2025 delivers critical updates for endocrinology specialists and related healthcare providers, reinforcing knowledge across a wide range of endocrine conditions. As endocrine care continues to evolve, staying informed on current guidelines and innovative treatment options is essential for effective patient management.

MedHub Central offers access to this course as a valuable resource for clinicians aiming to maintain clinical excellence in endocrinology. The program supports ongoing professional development and confidence in addressing complex endocrine disorders.